Impact of vaccine pause due to Thrombosis with thrombocytopenia syndrome (TTS) following vaccination with the Ad26.COV2.S vaccine manufactured by Janssen/Johnson & Johnson on vaccine hesitancy and acceptance among the unvaccinated population

Impact of vaccine pause due to Thrombosis with thrombocytopenia syndrome (TTS) following vaccination with the Ad26.COV2.S vaccine manufactured by Janssen/Johnson & Johnson on vaccine hesitancy and acceptance among the unvaccinated population

Show other versions (1)

<h4>Background</h4> In response to reports of thrombosis with thrombocytopenia syndrome (TTS) post-vaccination, the Johnson & Johnson (J&J) vaccine was paused and then restarted in April 2021. Our objective was to assess whether this pause adversely impacted vaccine confidence. &...

Full description

Bibliographic Details
Main Authors: Daniel A. Salmon, Holly B. Schuh, Rikki H. Sargent, Alexis Konja, Steven A. Harvey, Shaelyn Laurie, Brandy S. Mai, Leo F. Weakland, James V. Lavery, Walter A. Orenstein, Robert F. Breiman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553048/?tool=EBI
Show all versions (2)

Similar Items